Site Search
Professionals 150 results
Capabilities 49 results
Practice Area
Employee Benefits & Executive Compensation
With attorneys based in Chicago, New York and Washington, D.C., Winston’s Employee Benefits & Executive Compensation (EBEC) team represents a broad range of plan sponsors and offers clients not just deal support but the full suite of employee benefit services. These include public company reporting and executive compensation, employee benefits in mergers and acquisitions, qualified retirement plans and Title I investment advice, health and welfare benefit plans, employee stock ownership plans (ESOPs), and international human resources matters. And driven by a volatile labor market, we are partnering with clients to innovate plan structure and design, including cutting-edge services such as private exchange medical benefits, employee benefits in captive insurance, and fiduciary governance best practices. With decades of experience, our EBEC team maintains strong brand recognition, with clients describing our attorneys as “superb,” “very client-friendly,” “extremely responsive and able to bring forth the right resources,” and “having an “incredible breadth of knowledge.”
Practice Area
Environmental Litigation & Enforcement
With today’s rapidly evolving rules of engagement, paired with the often contentious nature of environmental disputes, clients rely on Winston for our practical experience and substantive knowledge of the broad-ranging issues involved in environmental litigation, enforcement, and investigations.
Region
Winston’s deep experience representing companies and investors across Latin America and the Caribbean has made the firm a “go-to” resource for the strategic development of our clients’ businesses and the vigorous protection of their interests in the region. With broad command of a diverse range of issues within the region’s key industry sectors, we advise Fortune 500 companies, government and quasi-governmental entities, financial institutions, private equity and other investors, domestic and international oil and gas exploration and production companies, refiners and shippers, and a range of commercial and infrastructure developers.
Experience 18 results
Experience
|July 17, 2025
D. Boral Capital Closes US$15M Robot Consulting IPO
Winston & Strawn LLP represented D. Boral Capital LLC and Craft Capital Management LLC in connection with the US$15M initial public offering of American Depositary Shares (ADSs) of Robot Consulting Co., Ltd. The offering consisted of 3,750,000 ADSs priced at $4.00 per ADS, and the company’s ADSs began trading on the Nasdaq Capital Market under the ticker symbol “LAWR” on July 17, 2025.
Experience
|March 31, 2025
Winston & Strawn assists Santa Fe Operating, LLC, a subsidiary of HRM Resources IV, LLC, a Kayne Anderson Capital Advisors sponsor-backed borrower, in reserve-based $300,000,000 lending facility with BOKF, NA, the proceeds of which were used to acquire producing oil and gas properties.
Experience
|August 6, 2024
Winston Represented Lincoln Property Company in its Strategic Investment in Centennial
Winston represented Lincoln Property Company a global, full-service real estate firm, in its strategic investment in the operating business of Dallas-based Centennial, a national retail real estate owner and operator. The partnership provides Centennial with the capital and resources to accelerate its national expansion while positioning Lincoln for new mixed-use development opportunities.
Insights & News 1,199 results
Article
|January 6, 2026
|5 Min Read
Guardrails Before Greenlights: How Gen AI Will Actually Shape E-discovery in 2026
This article was originally published in LegalTech News. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
In the Media
|January 5, 2026
|1 Min Read
Winston Lawyers Featured in Mealey’s International Arbitration Report
Winston & Strawn lawyers Laurens Wilkes, Gus Membiela, and Madison Haueisen were featured in the Mealey’s International Arbitration Report featuring commentary from international arbitration leaders discussing the use of an AI arbitrator for construction arbitrations. In their commentary Laurens, Gus, and Madison provide their thoughts on the legal, ethical, and practical implications of the American Arbitration Association’s International Centre for Dispute Resolution (AAA-ICDR) announcement.
Benefits Blast
|December 18, 2025
|5 Min Read
The Internal Revenue Service (the IRS) recently issued Notice 2026-5 which provides guidance on changes to health saving accounts (HSAs) enacted by the One Big Beautiful Bill Act (OBBBA).
Other Results 69 results
Site Content
A subset of biologics, a biosimilar is a biologic that is highly similar to an FDA-approved product, referred to as the reference product. Biosimilars have no clinically meaningful differences compared to a reference product in terms of safety, purity, and potency as demonstrated through human pharmacokinetic and pharmacodynamics studies. Because of their complexity, biosimilars are unlikely to be identical replicates of their comparable reference products.
Site Content
In the product liability context, epidemiology refers to the study of the incidence, distribution, and etiology of disease or harm in human populations. Epidemiological studies include a variety of different study designs, such as prospective and retrospective cohort studies, case-control studies, randomized controlled trials, and meta-analysis. Epidemiology is a critical, and sometimes mandatory, element for establishing general causation.